CureDuchenne Welcomes New Executive Director, Vice President of Medical Affairs, and Board Members October 24, 2023 Leading Duchenne Muscular Dystrophy Nonprofit Strengthens Leadership Team and Board Expertise Read More
Santhera Receives Positive CHMP Opinion Recommending Approval of AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy October 13, 2023 The Committee for Medicinal Products for Human Use (CHMP) has given a positive recommendation for AGAMREE’s approval in Europe. Read More